Sundaram Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 15-05-2024
- Paid Up Capital ₹ 4.32 M
as on 15-05-2024
- Company Age 17 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit -2857.14%
(FY 2023)
- Ebitda -2857.14%
(FY 2023)
- Net Worth -21.43%
(FY 2023)
- Total Assets -1.16%
(FY 2023)
About Sundaram Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.32 M, as per Ministry of Corporate Affairs (MCA) records.
Shantilal Shah and Amrut Shah serve as directors at the Company.
- CIN/LLPIN
U24233MH2007PTC168324
- Company No.
168324
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Mar 2007
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
- Apps
Who are the key members and board of directors at Sundaram Bio-Tech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shantilal Shah  | Director | 02-Mar-2007 | Current |
| Amrut Shah | Director | 02-Mar-2007 | Current |
Financial Performance and Corporate Structure Insights of Sundaram Bio-Tech.
Sundaram Bio-Tech Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 2857.14% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.43%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sundaram Bio-Tech?
In 2023, Sundaram Bio-Tech had a public holding of 13.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sundaram Bio-Tech?
Unlock and access historical data on people associated with Sundaram Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sundaram Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sundaram Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
